Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

2506, 2025

Zhasmina Mihaylova et al., Clinically Based Cetuximab Re-Challenge in Patients with RAS Wild-Type Metastatic Colorectal Cancer and Retrospective Analysis of Liquid Biopsies—Preliminary Data.

1906, 2025

Marianna Peroni et al., BRAF fusion as resistance mechanism to osimertinib in EGFR-mutated NSCLC: a case report and review of literature

1806, 2025

Alessandro Vanoli et al., HER2, HER3 and mismatch repair protein expression in stage IV small bowel adenocarcinoma: results from a multicenter series.

2805, 2025

Lorenzo Scappaticcio et al., Patient-specific factors, patient preference, and nodule size as implications in the initial surgery of high risk indeterminate thyroid nodules.

2805, 2025

Maria Antonietta Castaldi et al., BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient

2005, 2025

Mariavittoria Vescovo et al., Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications

705, 2025

Laura Antolino et al., TP53 Arg72Pro Polymorphism and Pancreatic Cancer Susceptibility: Assessing rs1042522 as a Risk Factor for Pancreatic Cancer

605, 2025

Francesca Boscolo Nata et al., Impact of intraoperative NBI on complete resections and recurrence in oral and oropharyngeal cancer

105, 2025

Esther Fernández-Galán et al., Integrating ctDNA testing for EGFR analysis in advanced non-small cell lung cancer: strategies for clinical laboratories

104, 2025

Laura Libera et al., KRAS/NRAS variants and copy number alterations prognostically stratify patients with sinonasal melanoma

103, 2025

Veronica Agostinelli et al., The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy

1802, 2025

HAL?M ÖZÇEV?K ET AL., Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective

12 Successivo

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Pubblicazioni

Leader in Italia nella ricerca e nella commercializzazione di kit diagnostici per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici